Genmab A/S
GMAB
$19.91
-$0.34-1.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 441.45% | -39.29% | 4.15% | 537.62% | 43.74% |
| Total Depreciation and Amortization | 96.28% | 32.95% | 23.63% | 5.87% | -62.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -254.78% | 2,631.13% | 42.37% | -273.93% | -20.82% |
| Change in Net Operating Assets | -28.00% | -403.55% | 53.62% | -85.18% | 105.84% |
| Cash from Operations | 60.57% | 0.70% | 242.69% | -52.74% | 341.52% |
| Capital Expenditure | -38.89% | 60.87% | 72.51% | 72.79% | 35.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 146.46% | -76.10% | 298.93% | -1,669.15% | -1,415.83% |
| Cash from Investing | 118.37% | -77.58% | -372.08% | -11,101.63% | -241.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -6.25% | 34.48% | -14.29% | 3.85% |
| Issuance of Common Stock | 22.22% | 7.50% | -77.46% | 84.38% | -94.64% |
| Repurchase of Common Stock | -33.33% | -7,450.00% | -8,608.57% | -1.29% | 45.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 113.50% | -1,492.45% | -43,141.51% | 1.59% | -117.65% |
| Foreign Exchange rate Adjustments | 215.93% | -90.94% | -30.18% | 252.52% | 26.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 485.98% | -40.30% | -622.07% | -108.31% | 228.99% |
